Another study identified five glycolysis-related mRNAs (GYS2, STMN1, PPFIA4, KDELR3, and ABCB6) which were associated with patients experience biochemical recurrence (BCR) after radical prostatectomy (RP) in patients with prostate adenocarcinoma [24]. This evidence concerns the gene GYS2 and prostate adenocarcinoma.